Ectopic hedgehog signaling causes cleft palate and defective osteogenesis by Hammond, NL et al.
  
Full Title: Ectopic Hedgehog signalling causes cleft palate and defective 
osteogenesis. 
 
Nigel L. Hammond1, Keeley J. Brookes1,2, Michael J. Dixon1,* 
 
1Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University 
of Manchester, Oxford Road, Manchester. M13 9PT, UK 
 
2Current address: Human Genetics, Life Sciences, University Park, University of Nottingham, 
Nottingham, NG7 2RD, UK 
 
*Corresponding author: Professor Michael Dixon, Michael Smith Building, University of Manchester, 
Oxford Road, Manchester M13 9PT. UK. E-mail: mike.dixon@manchester.ac.uk; Telephone: +44 
(0)161-275 5620; Fax: +44 (0) 161-275 5082. 
 
Conflict of interest: The authors have declared that no conflict of interest exists 
 
 




Cleft palate is a common birth defect that frequently occurs in human congenital 
malformations caused by mutations in components of the Sonic Hedgehog (SHH) signalling 
cascade. Shh is expressed in dynamic, spatio-temporal domains within epithelial rugae and 
plays a key role in driving epithelial-mesenchymal interactions that are central to 
development of the secondary palate. However, the gene regulatory networks downstream 
of Hedgehog (Hh) signalling are incompletely characterised. Here, we show that ectopic Hh 
signalling in the palatal mesenchyme disrupts oral-nasal patterning of the neural crest cell-
derived ectomesenchyme of the palatal shelves leading to defective palatine bone formation 
and fully penetrant cleft palate. We show that a series of Fox transcription factors, including 
the novel direct target Foxl1, function downstream of Hh signalling in the secondary palate. 
Furthermore, we demonstrate that Wnt/BMP antagonists, in particular Sostdc1, are positively 
regulated by Hh signalling, concomitant with down-regulation of key regulators of 
osteogenesis and BMP signalling effectors. Our data demonstrate that ectopic Hh-Smo 
signalling down-regulates Wnt/BMP pathways, at least in part by up-regulating Sostdc1, 
resulting in cleft palate and defective osteogenesis. 
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Specification, growth, elevation, adherence and fusion of the palatal shelves are essential 
mechanisms involved in secondary palate formation (Dixon et al., 2011; Mossey et al., 
2009). Disruption of these processes leads to cleft palate, a common congenital disorder 
that affects ~1:2500 live births (Mossey et al., 2009). Cleft palate causes major morbidity 
through problems with feeding, speech, hearing and social adjustment. Affected children 
require multidisciplinary care into adulthood at considerable cost to healthcare systems 
worldwide. The frequent occurrence and major burden imposed by cleft palate highlight the 
need to dissect the mechanisms underlying palatal development. Although substantial 
progress has been made identifying the mutations underlying syndromic forms of cleft 
palate, the developmental role of many of the mutated genes is unknown (Dixon et al., 
2011). 
Development of the mouse secondary palate mirrors that of humans; as a result the mouse 
is the major model organism for analysing palatogenesis (Bush and Jiang, 2012). In mice, 
palatal shelves initiate from the maxillary processes on embryonic day (E)11 grow lateral to 
the tongue during E12/E13 before re-orientating above the tongue during E14. 
Subsequently, the medial edge epithelia of apposed shelves adhere to form a midline 
epithelial seam, which degenerates to allow mesenchymal continuity across the palate by 
E15. In parallel, the oral and nasal palatal epithelia differentiate into stratified, squamous, 
keratinising and pseudostratified, ciliated epithelia, respectively. Similarly, the palatal 
mesenchyme differentiates into bony and muscular elements forming the hard and soft 
palate, respectively. Reflecting these different developmental fates, gene expression studies 
have revealed molecular heterogeneity along both the oral-nasal and anterior-posterior axes 
of the palatal shelves (Hilliard et al., 2005). 
Mutations in components of the Hedgehog (Hh) signalling pathway underlie several human 
congenital malformations which are associated with cleft palate (Cohen, 2010; Mansilla et 
  
al., 2006). Shh is expressed in epithelial rugae on the oral aspect of the palate, which initially 
define the anterior-posterior boundary of the palatal shelves, and act as signalling centres 
that drive epithelial-mesenchymal interactions (Lan and Jiang, 2009; Pantalacci et al., 2008; 
Rice et al., 2004; Rice et al., 2006). Thus, Shh signalling is linked spatio-temporally to both 
oral-nasal and anterior-posterior patterning of the secondary palate. Recent transgenic 
approaches to modulate Shh signalling within cranial neural crest cells (CNCC) (Jeong et al., 
2004), facial epithelia (Cobourne et al., 2009; Kurosaka et al., 2014; Lan and Jiang, 2009; 
Rice et al., 2004), and secondary palate mesenchyme (Lan and Jiang, 2009) have 
demonstrated the critical importance of this pathway to normal secondary palate 
development. Shh signalling regulates expression of the transcription factors Foxf1, Foxf2, 
Osr2, and the growth factors BMP2, BMP4 and Fgf10 in palatal mesenchyme (Lan and 
Jiang, 2009) but the Shh-induced pathways controlling epithelial-mesenchymal cross-talk 
remain incompletely characterised. 
In this study, we investigated how ectopic Hh signalling affects normal secondary palate 
development. Using a gain-of-function mouse model to activate Smoothened (Smo) 
signalling in the palatal mesenchyme (Osr2-IresCre;Smo+/M2), we demonstrate that ectopic 
Hh-Smo signalling results in fully penetrant cleft palate and defective palatine bone 
formation. Using transcriptional profiling and expression analyses, we demonstrate Hh-Smo 
signalling is expanded and disrupts oral-nasal patterning by driving the expression of several 
transcriptional repressors and antagonists of Hh, Wnt and BMP signalling pathways. We 
show Hh-Smo signalling up-regulates several Fox transcription factors, including the direct 
transcriptional target Foxl1. Furthermore, we reveal the dual Wnt/BMP antagonist, Sostdc1, 
is expressed ectopically in the nasal mesenchyme, coincident with down-regulation of 
nasally-expressed master regulators of osteogenesis (Sox9, Runx2), bone-related 
extracellular matrix proteoglycans (Dcn, Lum) and BMP signalling effectors (pSmad 1/5/9). 
Our data suggest Hh-Smo signalling negatively regulates Wnt/BMP pathways by up-
regulating antagonists, resulting in cleft palate and defective osteogenesis. 
  
Results 
Osr2-IresCre;Smo+/M2 mice have a complete cleft of the secondary palate 
To investigate the gene regulatory networks downstream of the Hh-Smo signalling cascade, 
we used Cre/loxP to constitutively activate Smo (SmoM2) (Xie et al., 1998) in the palatal 
mesenchyme in vivo (Osr2-IresCre) (Appendix Fig. 1). Osr2-IresCre;Smo+/M2 embryos, 
hereafter referred to as mutants, displayed a wide cleft of the secondary palate. Histological 
analysis of E13.5 mutant mice revealed smaller, abnormally-shaped palatal shelves 
compared with their wild-type littermates, which was most pronounced in the anterior and 
mid-regions, indicating reduced palatal outgrowth (Fig. 1A, B). By E14.5 wild-type palatal 
shelves had re-orientated above the tongue while those of mutant littermates had failed to 
elevate, were rounded in appearance and tooth germ development was arrested at the bud 
stage (Fig. 1C, D; arrowheads). These anomalies were more pronounced by E15.5, when 
mutant embryos displayed a fully penetrant complete cleft of the secondary palate (n=15) 
compared to the fused palate of wild-type littermates (Fig. 1E, F). To investigate the cause of 
smaller palatal shelves, we performed cell proliferation analysis using BrdU incorporation at 
E13.5, and revealed a significant proliferation defect in anterior and mid palatal regions while 
the posterior palate was unaffected (Appendix Fig. 2). 
Osr2-IresCre;Smo+/M2 mice have multiple skeletal defects 
We analysed alcian blue/alizarin red-stained skeletal preparations, which revealed defects in 
the viscerocranium of mutant embryos (Fig. 2A; E17, n=3). The anterior midline structures of 
the premaxilla and posterior regions of the maxilla were absent in mutant embryos, along 
with the associated palatine processes, revealing the presphenoid which is normally 
obscured (Fig. 2B). Mutant mandibles were shorter and showed anterior ossification defects 
with rudimentary condyloid processes and no defined coronoid processes (Fig. 2C).  
Transcriptional profiling reveals negative regulators of Hh, Wnt and BMP pathways 
are up-regulated in response to persistent Hh signalling. 
  
To gain insight into the gene regulatory networks affected by increased Hh-Smo signalling, 
we compared the transcriptomes of palatal shelves dissected from E13.5 wild-type and 
mutant embryos. Microarray analysis identified 580 differentially-expressed genes (p< 0.05) 
(E-MTAB-5518; Appendix Table 1; Appendix Fig. 3A), of which 327 genes were up-regulated 
in response to increased Hh-Smo signalling. These included known direct targets (Gli1, 
Ptch1, Ptch2, Hhip) and several members of the Fox family of transcription factors (Foxd1, 
Foxd2, Foxf1, Foxf2 and Foxl1). Over-representation Enrichment Analysis indicated 
significant enrichment of Gene Ontology terms including ‘mesenchyme development’, 
‘receptor serine/threonine kinase signalling’ and ‘cell fate commitment’ (Appendix Fig. 3B; 
Appendix Table 4). Further annotation of these gene groups revealed up-regulation of 
several transcriptional repressors and antagonists of Hh (eg. Ptch1, Hhip, Cdon), Wnt and 
BMP (eg. Sostdc1, Twsg1) signalling pathways. 
Hh-Smo direct and downstream targets are up-regulated throughout the palatal 
mesenchyme 
Subsequently, we investigated the expression of known Hh direct targets (Gli1, Ptch1) and 
candidate targets from the microarray analysis using a combination of whole-mount and 
section in-situ hybridisation. Gli1 and Ptch1 are normally expressed in rugae epithelium and 
the underlying mesenchyme on the oral side of the palate. However, their expression was 
expanded into the tooth germ and nasal mesenchyme of mutant embryos (Fig. 3A-H) while 
reduced expression was noted in epithelial rugae (Fig 3C, D, G, H). Ectopic expression of 
Gli1 and Ptch1 was also observed in the mandibular mesenchyme (Fig. 3D, H; arrows), 
correlating with Osr2-IresCre expression (Appendix Fig. 1C).  
Members of the Fox transcription factor family, including Foxf1 and Foxf2, have been 
implicated down-stream of Hh signalling during facial and secondary palate development 
(Lan and Jiang, 2009; Nik et al., 2016; Xu et al., 2016). Foxf2 was expressed throughout the 
anterior-posterior length of the oral palatal mesenchyme in wild-type embryos with increased 
  
expression underlying rugae (Fig. 3I, K). In contrast, Foxf2 was markedly up-regulated in the 
oral and nasal mesenchyme of mutant embryos (Fig. 3J, L). Transcriptional profiling 
identified Foxl1 as the highest up-regulated Fox factor (Appendix Table 1; Appendix Table 2) 
and has not been implicated in palate development. Foxl1 was expressed in the oral palatal 
mesenchyme of wild-type embryos associated with rugae. However, in mutant embryos, 
Foxl1 was markedly up-regulated and expanded from the oral to nasal palatal mesenchyme 
both in anterior and posterior regions of the palate (Fig. 3M-P). Similar to known Hh direct 
targets, ectopic expression of both Fox factors was observed in the lingual aspect of the 
mandibular mesenchyme (Fig. 3P; arrow).   
Elevated Hh-Smo signalling also up-regulated several Wnt/BMP antagonists. We 
investigated the expression of Sostdc1, a dual Wnt/BMP secreted antagonist with reported 
roles in the spatial patterning of teeth and rugae (Ahn et al., 2010; Cho et al., 2011; Lee et 
al., 2011). Sostdc1 was expressed in inter-rugae domains in the anterior palatal epithelium 
and the posterior palate (Fig. 3Q, S) (Lee et al., 2011; Welsh and O'Brien, 2009). In mutant 
embryos, Sostdc1 was expressed ectopically in the lingual and nasal mesenchyme of the 
palate while expression in the posterior palate and mandible was also up-regulated (Fig. 
3R). Real-time qPCR confirmed significant up-regulation of all these genes in the palatal 
shelves of mutant embryos (Fig. 3U).  
Sequential rugae interposition is blocked and Shh is down-regulated in Osr2-
IresCre;Smo+/M2 embryos 
Whole-mount analysis of Shh targets indicated reduced numbers of rugae in mutant 
embryos at E13.5 (Fig. 3; arrowheads). Subsequently, Shh expression from E13.5 - E15.5 
showed the sequential addition of up to eight rugae in wild-type embryos (Appendix Fig. 4A-
C), while mutants developed only three rugae (Appendix Fig. 4D-F). Furthermore, at E15.5 
Shh expression was secondarily down-regulated in mutant rugae, while expression persisted 
in wild-type embryos (Appendix Fig. 4D,H). 
  
Extracellular matrix proteoglycans in the nasal palatal mesenchyme are down-
regulated 
Transcriptional profiling indicated that the extracellular matrix proteins decorin (Dcn), lumican 
(Lum) and keratocan (Kera) were amongst the most significantly down-regulated genes 
(Appendix Table 3; Appendix Fig. 2A). These matricellular proteins are members of the small 
leucine-rich proteoglycan (SLRP) family with multiple roles in osteogenesis (Raouf et al., 
2002; Waddington et al., 2003). Expression analyses in wild-type embryos showed Dcn and 
Lum were restricted to the nasal mesenchyme of the palate. In agreement with the 
microarray analysis, expression of both genes was down-regulated in mutant palatal 
mesenchyme while expression elsewhere was unaffected (Fig. 4A-H). Similarly, Dlx5, a 
factor crucial for osteoblast differentiation (Acampora et al., 1999), is expressed in the 
anterior nasal mesenchyme of wild-type palatal shelves (Fig. 4I, K) but was down-regulated 
in the palatal mesenchyme of mutant embryos (Fig. 4J, L). Real-time qPCR confirmed the 
reduction of Dcn and Lum, however Dlx5 was not significant (Fig. 4M).  
Master regulators of osteogenesis are down-regulated 
Subsequently, we analysed the expression of key transcriptional effectors of osteogenesis, 
Sox9 and Runx2, which are regulated by Wnt/Bmp crosstalk (Gaur et al., 2005; Pan et al., 
2008). Immunohistochemical analyses of Sox9 and Runx2 at E13.5 revealed both proteins 
were expressed in overlapping domains within the nasal palatal mesenchyme (Fig. 5A, C, 
E). Sox9 was also highly expressed in developing craniofacial cartilages (Fig. 5A, E). The 
expression of both proteins was dramatically down-regulated in the nasal mesenchyme while 
expression elsewhere was unaffected (Fig. 5B, D, F). Similarly at E14.5, Sox9 and Runx2 
were expressed in overlapping domains in the re-orientated nasal mesenchyme directly 
beneath the midline epithelial seam (Fig. 5G, I, K) while the expression of both proteins was 
markedly down-regulated in the nasal mesenchyme of mutant embryos (Fig. 5H, J, L). Sox9 
and Runx2 are critical factors in orchestrating multiple steps of intramembranous ossification 
and their expression in wild-type palatal mesenchyme defines the nasal mesenchymal 
  
contribution to palatal growth, fusion and bone formation (Fig 5A, C, E, G, I, K). Since Sox9 
and Runx2 were down-regulated and Sostdc1 is a BMP antagonist (Wu et al., 2008), we 
analysed whether BMP signalling was affected in mutant embryos. Immunofluorescence for 
pSmad 1/5/9 revealed the effectors of BMP signalling were also down-regulated in the nasal 
mesenchyme at E13.5 and the future palatine bone regions at E14.5 (Fig. 5M-P). 
Collectively, these results demonstrate ectopic Hh-Smo signalling in the nasal mesenchyme 
down-regulates BMP signalling, concomitant with up-regulation of Wnt/BMP antagonist 
Sostdc1, resulting in defective osteogenesis and cleft palate.  
Foxl1 is a direct target of Gli1 in the secondary palate 
To determine if Sostdc1 and Foxl1 are direct targets of Hh signalling, we analysed the 
promoters (-1 kb) of these genes for candidate Gli binding sites. No Gli sites were found 
near Sostdc1. However, we identified two highly conserved candidate binding sites in the 
Foxl1 promoter (-237 and -371 from the TSS), with one mismatch from the Gli consensus 
(Appendix Fig. 5A), in regions of accessible chromatin (Appendix Fig. 5B). Gli1 ChIP-qPCR 
analyses of E13.5 palatal shelves demonstrated significant enrichment of Gli1 on the Foxl1 
promoter and also known direct targets, Ptch1 and Gli1 (Appendix Fig. 5C). This is the first 
report to demonstrate Foxl1 is a direct target of Gli1 in vivo. 
Discussion 
Spatio-temporal Hh-Smo signalling defines a gene regulatory network which patterns the 
oral axis of the secondary palate. Recent research has established that epithelial Shh 
expressed within rugae (Pantalacci et al., 2008) signals to the underlying mesenchyme to 
activate Smo (Lan and Jiang, 2009; Rice et al., 2004) and direct gene expression and cell 
fate through Gli transcription factors. Rice and colleagues showed that Shh signalling is 
crucial for palate development as disruption of Fgf10-Fgfr2b-Shh mesenchymal-epithelial 
signalling results in cleft palate (Rice et al., 2004), while targeted loss of the key Shh 
transducer, Smo, in palatal mesenchyme also results in cleft palate (Lan and Jiang, 2009). 
  
Conversely, transgenic expression of Shh in all epithelial tissues results in a severe 
craniofacial phenotype with cleft palate (Cobourne et al., 2009). However, the molecular 
mechanisms down-stream of Hh-Smo signalling within the secondary palate remain poorly 
characterised.  
Mutant mouse studies to uncover the molecular mechanisms driving secondary palate 
development are often confounded by early embryonic lethality or gross craniofacial 
abnormalities. However, the recent generation of Osr2-IresCre mice (Lan et al., 2007) allows 
tissue-specific manipulation of genes involved in palate development. While the use of Cre-
based mouse models to interrogate gene function are an aggressive tool which can disrupt 
normal physiological gene expression, such an approach has been used successfully to 
uncover targets of Hh signalling in the early embryonic face, limb, palate and brain (Jeong et 
al., 2004; Vokes et al., 2008; Lan and Jiang, 2009; Heine and Rowitch, 2009). In this study, 
we generated a palate-specific Smo gain-of-function mouse model by targeting constitutively 
active Smo (Xie et al., 1998) to the palatal mesenchyme. We found that mutant embryos 
were characterised by a fully penetrant wide cleft of the secondary palate with various 
skeletal defects. Taken together, this clearly illustrates a precise level of Hh-Smo signalling 
is required for normal palate development. 
Patterning of the secondary palate is complex, with molecular heterogeneity along both the 
oral-nasal and anterior-posterior axes (Hilliard et al., 2005). We, and others (Han et al., 
2009; Lan and Jiang, 2009; Rice et al., 2006), have shown that effectors of Hh-Smo 
signalling are expressed on the oral side of the palate whilst the nasal side is reportedly 
characterised by TGFβ/BMP mediators (Iwata et al., 2011; Parada and Chai, 2012). We 
demonstrated that elevated Hh-Smo signalling resulted in up-regulation and expansion of 
direct and down-stream targets of the Hh pathway within the palatal mesenchyme. Using 
transcriptional profiling and gene ontology analyses, we identified and characterised several 
  
up-regulated transcriptional repressors and Wnt/BMP antagonists in particular Foxf2, Foxl1 
and Sostdc1.  
Members of the Fox transcription factor family (Foxd1, Foxd2, Foxc2, Foxf1 and Foxf2) are 
dependent on Smo signalling in the early developing face, leading to the suggestion that Fox 
factors are the mediators of Hh-Smo signalling (Jeong et al., 2004). Indeed, loss of Smo in 
the palatal mesenchyme also results in down-regulation of Foxf1 and Foxf2 (Lan and Jiang, 
2009). Our data demonstrate that Foxf1, Foxf2 and the novel target Foxl1 are all robustly up-
regulated in response to increased Hh-Smo signalling within the palate, confirming these as 
Smo-dependent targets. Mutations in FOXF2 have been associated with cleft palate 
(Jochumsen et al., 2008) while mice deficient in either Foxf1 or Foxf2 are born with cleft 
palate (Lan and Jiang, 2009; Nik et al., 2016; Xu et al., 2016). We identified and 
characterised the expression of the novel Foxl1 in the secondary palate and demonstrated 
that Foxl1 is a direct target of Gli1. Although Foxl1-/- mice are viable, most mutant mice die 
before weaning, attributed to impaired development of the gastrointestinal tract (Kaestner et 
al., 1997). However, secondary palate formation has not been investigated in these mice 
and may be a contributing factor. Alternatively, other Fox family members may compensate 
for the loss of Foxl1. In support of this hypothesis, Foxf1 and Foxl1 have similar functions in 
the developing stomach and intestine (Madison et al., 2009), while partial functional 
redundancy between Foxf1 and Foxf2 has been demonstrated in the secondary heart field 
(Hoffmann et al., 2014) and palate (Xu et al., 2016). The function of Foxl1 during palate 
development remains unknown, however, studies in other tissues have revealed Foxl1 (in 
addition to Foxf1 and Foxf2) can indirectly affect epithelial proliferation via modulation of 
Wnt-β-catenin signalling (Kaestner et al., 1997; Madison et al., 2009; Perreault et al., 2001). 
Therefore we postulate Foxl1 may play a role in coordinating palatal growth via epithelial-
mesenchymal feedback. 
  
Expansion of Hh-Smo signalling into the nasal mesenchyme resulted in a gain of oral gene 
expression concomitant with a loss of nasal gene expression, resulting in impaired 
osteogenesis of the palatine bones. We showed down-regulation of extracellular matrix 
proteoglycans in the palatal mesenchyme which play multiple roles in osteogenesis (Raouf 
et al., 2002; Waddington et al., 2003). Furthermore, we confirmed Sox9 and Runx2 were 
down-regulated along with a failure of BMP signalling in the nasal mesenchyme of the 
palate, coincident with ectopic expression of the dual Wnt/BMP antagonist, Sostdc1. Ectopic 
expression of Sostdc1 in CNCCs directly antagonises BMP-induced osteogenesis, resulting 
in cleft palate (Wu et al., 2008). Taken together, our data suggest that ectopic Sostdc1 
driven by expanded Hh-Smo signalling, at least in part underlies the failure of BMP signalling 
and osteogenesis defects in mutant embryos. 
During tooth and lip development, Shh negatively regulates Wnt signalling (Ahn et al., 2010; 
Kurosaka et al., 2014), while Sostdc1 knockout mice have elevated Wnt signalling and 
supernumerary teeth (Ahn et al., 2010; Cho et al., 2011; Zhang et al., 2009). Our 
transcriptome data identified several up-regulated Wnt antagonists, suggesting that Wnt 
signalling may be affected by ectopic Hh-Smo signalling. Furthermore, we noted that 
epithelial Gli1 and Ptch1 were reduced at E13.5 and Shh expression was secondarily down-
regulated in rugae at E15.5, which we suggest is due to epithelial-mesenchymal negative 
feedback mechanisms. Negative feedback via Sostdc1 has been suggested for tooth and 
rugae patterning (Ahn et al., 2010; Lee et al., 2011). Thus, we speculate a Wnt-Hh-Sostdc1 
negative feedback loop may also be present during secondary palate development. 
However, it is likely that other Wnt/BMP antagonists act in concert with Sostdc1 to reinforce 
Wnt and BMP antagonism. In support of this hypothesis, pharmacological inhibition or 
genetic inactivation of Wnt antagonists rescued cleft palate in Pax9-/- embryos (Jia et al., 
2017; Li et al., 2017). Further work is needed to elucidate if Sostdc1 and other Wnt/BMP 
antagonists are direct targets of Hh-Smo signalling during secondary palate development.  
  
In this study we identify Foxl1 as a direct target of Gli1 in vivo. In order to delineate all Hh-
Smo direct from down-stream targets on a genome-wide scale, ChIP-seq datasets for the Gli 
transcription factors (Gli1, Gli2 and Gli3) on secondary palate tissue would enable the direct 
regulatory networks to be uncovered, and will be addressed in future studies. 
Materials and Methods 
Detailed Methods are in the Appendix. Microarray data has been deposited in ArrayExpress 
with the accession E-MTAB-5518. 
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Fig. 1. Osr2-IresCre;Smo+/M2 mice have fully penetrant cleft palate. (A-F) Histological 
analyses indicate mutant embryos have severe defects in secondary palate development. 
Mutant palatal shelves are smaller in size from E13.5 with marked reduction in vertical 
growth of the palatal shelves (A,B). Although mutant palatal shelves appear to reorientate by 
E14.5, they are abnormally shaped and far apart (C,D), resulting in in a wide cleft of the 
secondary palate by E15.5 (E,F). Tooth germ development is also arrested at the bud stage 
in mutant embryos (C-F). ps, palatal shelf; t, tongue. Scale bars: A-H, 300μm.  
 
Fig. 2. Osr2-IresCre;Smo+/M2 mice have skeletal abnormalities and lack the palatine 
bones. (A-C) Whole-mount skeletal preparations stained with alcian blue and alizarin red 
reveal multiple defects in the mutant skeleton at E17.5. (A) Skeletal abnormalities include 
truncated fore- and hind-limbs with cartilage and ossification defects. (B) Detailed analysis of 
the craniofacial skeleton reveals multiple abnormalities of the viscerocranium. Mutant 
embryos demonstrate reduced ossification of the maxilla (mx) and premaxilla along with 
absence of the palatine and palatine processes of both the premaxilla and maxilla. (C) 
Mutant embryos also have a shorter mandible (green arrow, wild-type; red arrow, mutant) 
with rudimentary angular and condyloid processes and no defined coronoid process. Mutant 
mandibles also show reduced ossification anteriorly. md, mandible; mx, maxilla; pmx, 
premaxilla; p, palatine bone; ppp, palatine process of the palatine; ppmx, palatine process of 
the maxilla; pppmx, palatine process of the premaxilla; als, alisphenoid; fr, frontal bone; ps, 
presphenoid; bs, basosphenoid; bo, basioccipital; eo, exoccipital; agp, angular process; cdp, 
condyloid process; crp, coronoid processes. 
 
Fig. 3. Hedgehog direct and down-stream targets are up-regulated in Osr2-
IresCre;Smo+/M2 embryos. Whole-mount (A,B,E,F,I,J,M,N,Q,R) and section in situ 
(C,D,G,H,K,L,O,P,S,T) hybridisation for direct targets Gli1 (A-D) and Ptch1 (E-H) 
demonstrate they are associated with rugae on the oral side of E13.5 wild-type palates 
(A,C,E,G). Gli1 and Ptch1 are up-regulated and expanded from the oral to nasal 
mesenchyme of mutant embryos (B,D,F,H). Foxf2 is expressed in the oral mesenchyme 
along the anterior-posterior length of the palate while Foxl1 is strongly expressed in the 
mesenchyme underlying rugae (I,K,M,O). Up-regulation and expansion of both Fox factors is 
seen in mutant palates (J,N,L,P). Expression of Sostdc1 is observed in inter-rugae domains 
of the epithelium and in the posterior palate In contrast, Sostdc1 is ectopically expressed in 
the nasal mesenchyme and up-regulated in the posterior palate of mutants (Q-T). Ectopic 
expression of all targets is seen in the mandibular mesenchyme of mutant embryos 
(D,H,L,P,T; arrows). (M) Real-time qPCR analysis of E13.5 palatal shelves confirms up-
regulation of all targets (p<0.05 *, p<0.01 **; Mann-Whitney U test, n=5). ps, palatal shelf; t, 
tongue; md, mandible. Scale bars: C,D,G,H,K,L,O,P,S,T 100 μm. 
 
Fig. 4. Extracellular matrix proteoglycans are down-regulated in Osr2-IresCre;Smo+/M2 
embryos. Whole-mount (A,B,E,F,I,J) and section in situ (C,D,G,H,K,L) hybridisation for the 
extracellular matrix genes Dcn (A-D), Lum (E-H) and the homeobox transcription factor Dlx5 
(I-L) demonstrate Dcn and Lum are expressed in the nasal mesenchyme throughout the 
anterior-posterior length of the palatal shelves in E13.5  wild-type embryos, while Dlx5 is 
also expressed in the nasal mesenchyme in the anterior region of the palatal shelves 
(A,C,E,G,I,K). Mutant embryos show loss of expression of these genes in the palatal shelves 
(B,D,F,H,J,L). (M) Real-time qPCR data confirm significantly reduced levels of mRNA for 
Dcn and Lum (p<0.05 *, Mann-Whitney U test, n=4). ps, palatal shelf; t, tongue; md, 





Fig. 5. Master regulators of osteogenesis are down-regulated in the nasal palatal 
mesenchyme of Osr2-IresCre;Smo+/M2 embryos. (A-F) Immunostaining for Sox9 (A,B; 
red) and Runx2 (C,D; green) in adjacent sections at E13.5 indicate both markers are 
expressed in overlapping domains in the nasal mesenchyme of wild-type palatal shelves 
(A,C,E; arrows). Sox9 is also highly expressed in the developing nasal cartilage 
(arrowheads) and extends into the mesenchyme beneath the medial edge epithelia (A,E) 
while Runx2 is also expressed in the odontogenic mesenchyme (C,E). Conversely, in mutant 
palatal shelves, expression of both markers is absent from the nasal palatal mesenchyme 
while expression in the nasal cartilage (arrowheads) and odontogenic mesenchyme is 
unaffected (B,D,F). (G-L) At E14.5, Sox9 is expressed in the mesenchyme beneath the 
midline epithelial seam (G,K), while Runx2 has a characteristic expression pattern in the 
future bone condensations of the wild-type palate (I,K). Both markers are excluded from the 
mesenchyme along the oral aspect of the horizontal palate (G,I,K). In contrast, expression of 
both markers is absent from the palatal mesenchyme of the mutant palate while expression 
in the nasal cartilages (arrowheads) and associated structures is unaffected (H,J,L). pSmad 
1/5/9 is expressed in the nasal mesenchyme at E13.5 and future palatine bone mesenchyme 
at E14.5 in wild-type embryos (M,N; red) but is absent from these regions in mutant embryos 
(O,P). Auto-fluorescence of red blood cells is identified by triple immunofluorescent images 
(M-P; yellow). ps, palate; t, tongue; md, mandible. Scale bars: A-P, 100 μm. 
 
 
